Cargando…

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy

Detalles Bibliográficos
Autores principales:	Mangala, Lingegowda S., Wang, Hongyu, Jiang, Dahai, Wu, Sherry Y., Somasunderam, Anoma, Volk, David E., Lokesh, Ganesh L. R., Li, Xin, Pradeep, Sunila, Yang, Xianbin, Haemmerle, Monika, Rodriguez-Aguayo, Cristian, Nagaraja, Archana S, Rupaimoole, Rajesha, Bayraktar, Emine, Bayraktar, Recep, Li, Li, Tanaka, Takemi, Hu, Wei, Ivan, Cristina, Gharpure, Kshipra M, McGuire, Michael H., Thiviyanathan, Varatharasa, Zhang, Xinna, Maiti, Sourindra N., Bulayeva, Nataliya, Choi, Hyun-Jin, Dorniak, Piotr L., Cooper, Laurence J.N., Rosenblatt, Kevin P., Lopez-Berestein, Gabriel, Gorenstein, David G., Sood, Anil K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119196/ https://www.ncbi.nlm.nih.gov/pubmed/33793423 http://dx.doi.org/10.1172/jci.insight.149896

Ejemplares similares

FABP4 as a key determinant of metastatic potential of ovarian cancer
por: Gharpure, Kshipra M., et al.
Publicado: (2018)

ADH1B promotes mesothelial clearance and ovarian cancer infiltration
por: Gharpure, Kshipra M., et al.
Publicado: (2018)

Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2016)

Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
por: Haemmerle, Monika, et al.
Publicado: (2017)

MicroRNA therapeutics: principles, expectations, and challenges
por: Rupaimoole, Rajesha, et al.
Publicado: (2011)

Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis
por: Nagaraja, Archana S., et al.
Publicado: (2015)

Identification of Thioaptamer Ligand against E-Selectin: Potential Application for Inflamed Vasculature Targeting
por: Mann, Aman P., et al.
Publicado: (2010)

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2019)

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2022)

Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas
por: WU, JEAN, et al.
Publicado: (2014)

Hypoxia Mediated Downregulation of miRNA Biogenesis Promotes Tumor Progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2014)

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
por: Wu, Sherry Y., et al.
Publicado: (2016)

Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
por: Nagaraja, Archana S., et al.
Publicado: (2021)

Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
por: Bayraktar, Emine, et al.
Publicado: (2023)

Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2
por: Rytelewski, Mateusz, et al.
Publicado: (2016)

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2016)

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
por: Gao, Chao, et al.
Publicado: (2021)

Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
por: Lara, Olivia D., et al.
Publicado: (2020)

Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting
por: Mann, Aman P., et al.
Publicado: (2010)

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
por: Kanlikilicer, Pinar, et al.
Publicado: (2017)

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
por: Yang, Lifeng, et al.
Publicado: (2014)

A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells
por: Liu, Haoran, et al.
Publicado: (2018)

Pan-cancer genomic analysis links 3’UTR DNA methylation with increased gene expression in T cells
por: McGuire, Michael H., et al.
Publicado: (2019)

Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer
por: Dasari, Santosh K., et al.
Publicado: (2023)

A High-Throughput Small Molecule Screen Identifies Ouabain as Synergistic with miR-34a in Killing Lung Cancer Cells
por: Rupaimoole, Rajesha, et al.
Publicado: (2020)

Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype
por: Ma, Shaolin, et al.
Publicado: (2021)

Targeting KRas-dependent tumor growth, circulating tumor cells and metastasis in vivo by clinically significant miR-193a-3p
por: Seviour, Elena G., et al.
Publicado: (2016)

PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway
por: Elsayed, Abdelrahman M., et al.
Publicado: (2021)

ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy
por: Yasukawa, Maya, et al.
Publicado: (2016)

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer
por: Rabinowicz, Noa, et al.
Publicado: (2017)

Neighborhood matters: Response to EZH2 methyltransferase inhibitors
por: Gharpure, Kshipra M, et al.
Publicado: (2013)

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2016)

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2023)

Calcium Dependent FAK/CREB/TNNC1 Signaling Mediates the Effect of Stromal MFAP5 on Ovarian Cancer Metastatic Potential
por: Leung, Cecilia S., et al.
Publicado: (2014)

Autocrine Effects of Tumor-Derived Complement
por: Cho, Min Soon, et al.
Publicado: (2014)

Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy
por: Offor, Obiageli, et al.
Publicado: (2018)

Targeting CCR2(+) macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer
por: Wu, Yutuan, et al.
Publicado: (2022)

Uterus-targeted liposomes for preterm labor management: studies in pregnant mice
por: Refuerzo, Jerrie S., et al.
Publicado: (2016)

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer
por: Kanlikilicer, Pinar, et al.
Publicado: (2018)

Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
por: Kanlikilicer, Pinar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_krnvlfeqbsvpabq1s5a59mn4md